Manufacturing will take place at Kyocera’s Vancouver, Wash., facility. The collaboration includes the manufacturing of all FDA-approved Silicon Nitride interbody devices.
The deal will assist Amedica in meeting market demands. The company has sold 14,000 devices worldwide.
More Articles on Devices:
Invibio Launches New Corporate Identity
Intelligent Implant Systems Granted FDA Clearance for Marauder Spine System
Tyber Medical Closes Initial Private Equity Funding Round
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
